{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:10Z","timestamp":1786119430390,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,24]]},"abstract":"<jats:p>\n                    Beh\u00e7et disease (BD) is an inflammatory disorder with significant ocular involvement. Angiopoietins regulate vascular stability, while EphrinB2\/EphB4 interactions are essential for retinal neovascularization and endothelial behavior. Endocan, a marker of endothelial activation, contributes to inflammatory processes by mediating leukocyte migration. This cross-sectional study investigates the role of angiopoietins, EphrinB2\/EphB4 signaling, and endocan in the development of active uveitis in BD patients. We recruited 29 BD patients with active eye involvement (group 1), 31 BD patients without eye involvement (group 2), and 30 healthy controls (group 3). Serum tyrosine protein kinase receptor (Tie-2), angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), EphrinB2, EphB4, and endocan levels were determined by the enzyme-linked immunosorbent assay method. A statistically significant difference was found between the Ang-1, Ang-2, Tie-2, EphrinB2, EphB4, and endocan levels of the 3 different groups in the study (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Between the patients with panuveitis and patients with only posterior or anterior uveitis, serum Ang-1 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), Tie-2 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), EphrinB2 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), EphB4 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.001), and endocan (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.002) levels had statistically significant differences. The highest and significant correlation was found between EphrinB2 and EphB4 (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.931,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). This was followed by a high level of significant correlation between Ang-1 and Ang-2 (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.845,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). In the group with active uveitis, EphB4 (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.774), Ang-2 (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.763), and Tie-2 (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.701) were negatively and highly significantly correlated with best corrected visual acuity (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Ang-1, Ang-2, Tie-2, EphrinB2, EphB4, and endocan regulate vascular stability, retinal neovascularization, and inflammation, potentially contributing to BD-associated uveitis. These findings could have important implications for the diagnosis and management of ocular involvement of BD.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000048261","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T07:03:13Z","timestamp":1777273393000},"page":"e48261","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of angiopoietin-1, angiopoietin-2, Tie-2, EphrinB2, EphB4, and endocan serum level in patients with Beh\u00e7et disease: A cross-sectional observational study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-6512","authenticated-orcid":false,"given":"Bet\u00fcl","family":"G\u00f6k\u00e7ek Barutcigil","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Tekirda\u011f City Hospital, Tekirda\u011f, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2882-6755","authenticated-orcid":false,"given":"Emine","family":"\u00c7inici","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Atat\u00fcrk University School of Medicine, Erzurum, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-3564","authenticated-orcid":false,"given":"Esra","family":"Laloglu","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Atat\u00fcrk University School of Medicine, Erzurum, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260622","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","article-title":"Ocular involvement of Beh\u00e7et\u2019s syndrome: a comprehensive review.","volume":"49","author":"Ozyazgan","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-20260622","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004397-200604620-00017","article-title":"Beh\u00e7et disease.","volume":"46","author":"Yates","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R3-20260622","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1097\/MD.0000000000000494","article-title":"Beh\u00e7et disease with vascular involvement: effects of different therapeutic regimens on the incidence of new relapses.","volume":"94","author":"Alibaz-Oner","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R4-20260622","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients.","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R5-20260622","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology.","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"R6-20260622","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye"},{"key":"R7-20260622","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation.","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat Med"},{"key":"R8-20260622","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.ajpath.2012.06.043","article-title":"Eph\/ephrin signaling in injury and inflammation.","volume":"181","author":"Coulthard","year":"2012","journal-title":"Am J Pathol"},{"key":"R9-20260622","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/147323000603400505","article-title":"Expression of ephrin in retinal neovascularization and iris rubeosis.","volume":"34","author":"Yuuki","year":"2006","journal-title":"J Int Med Res"},{"key":"R10-20260622","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0898-6568(03)00072-X","article-title":"Role of ephrin B2 in human retinal endothelial cell proliferation and migration.","volume":"15","author":"Steinle","year":"2003","journal-title":"Cell Signal"},{"key":"R11-20260622","doi-asserted-by":"crossref","first-page":"F960","DOI":"10.1152\/ajprenal.00020.2006","article-title":"Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.","volume":"291","author":"Baldwin","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"R12-20260622","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1007\/s11033-020-05470-y","article-title":"The critical role of the interplays of EphrinB2\/EphB4 and VEGF in the induction of angiogenesis.","volume":"47","author":"Du","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R13-20260622","first-page":"129","article-title":"Assessment of endocan serum level in patients with Beh\u00e7et disease: relation to disease activity and carotid intima media thickness.","volume":"27","author":"Hassan","year":"2020","journal-title":"Egypt J Immunol"},{"key":"R14-20260622","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","article-title":"Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease.","volume":"70","author":"Balta","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R15-20260622","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3109\/1354750X.2011.587893","article-title":"Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?","volume":"16","author":"Paulus","year":"2011","journal-title":"Biomarkers"},{"key":"R16-20260622","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1111\/aos.14230","article-title":"Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.","volume":"98","author":"Zur","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R17-20260622","doi-asserted-by":"crossref","first-page":"e0200365","DOI":"10.1371\/journal.pone.0200365","article-title":"Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in na\u00efve diabetic macular edema: the VITAL study.","volume":"13","author":"Iglicki","year":"2018","journal-title":"PLoS One"},{"key":"R18-20260622","first-page":"225","article-title":"Beh\u00e7et\u2019s disease in Japan; ophthalmological aspects.","volume":"76","author":"Mishima","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R19-20260622","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s00380-015-0686-9","article-title":"Clinical significance of angiopoietin-1 in Behcet\u2019s disease patients with vascular involvement.","volume":"31","author":"Bassyouni","year":"2016","journal-title":"Heart Vessels"},{"key":"R20-20260622","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jbspin.2010.01.014","article-title":"Serum angiopoietin-1 level is increased in patients with Beh\u00e7et\u2019s disease.","volume":"77","author":"Choe","year":"2010","journal-title":"Joint Bone Spine"},{"key":"R21-20260622","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15216540600756004","article-title":"Putative dual role of ephrin-Eph receptor interactions in inflammation.","volume":"58","author":"Ivanov","year":"2006","journal-title":"IUBMB Life"},{"key":"R22-20260622","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1167\/iovs.17-22945","article-title":"Endocan blockade suppresses experimental ocular neovascularization in mice.","volume":"59","author":"Su","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-20260622","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s41433-020-01309-9","article-title":"Longer-acting treatments for neovascular age-related macular degeneration \u2013 present and future","volume":"35","author":"Iglicki","year":"2021","journal-title":"Eye"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:17Z","timestamp":1786039697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":23,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048261","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}